COMMUNIQUÉS West-GlobeNewswire

Rezolute Announces $25 Million Private Placement -- Potential Total Investment of $45 Million

07/01/2019 - 14:39

REDWOOD CITY, Calif., Jan. 07, 2019 (GLOBE NEWSWIRE) -- Rezolute, Inc. (“Rezolute” or “Company”) (OTCQB:RZLT), a clinical stage biopharmaceutical company specializing in the development of innovative drug therapies for [...]

Evoke Pharma Signs Commercial and Financial Agreement for its Lead Product Gimoti™ in the U.S. with Novos Growth Partners

07/01/2019 - 14:30

Novos to provide fully integrated commercial function for Evoke and non-dilutive financing for the commercialization of Gimoti, extending cash runway into 2020 Evoke will retain greater than 80% of product profits [...]

Bellerophon Announces Top-line Results from Cohort 1 of the INOpulse® Phase 2b Clinical Trial for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease

07/01/2019 - 14:30

Statistically Significant Improvements in Multiple Clinically Meaningful Activity Parameters Demonstrated WARREN, N.J., Jan. 07, 2019 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or [...]

Homology Medicines Advances First Gene Editing Development Candidate into IND-Enabling Studies for Pediatric Patients with Phenylketonuria

07/01/2019 - 14:30

- Data Demonstrates Highly Efficient and Selective In Vivo Gene Editing in a Humanized Murine Model - - New Internal GMP Manufacturing Capability to Support Gene Therapy and Gene Editing Programs - BEDFORD, Mass., Jan. [...]

Assure Holdings Appoints Paul Webster as Vice President of Strategy

07/01/2019 - 14:30

DENVER, Jan. 07, 2019 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “ Company ” or “ Assure ”) (TSXV: IOM; OTCPK: ARHH), a provider of intraoperative neuromonitoring services, has appointed Paul Webster as its vice [...]

PSIQ Begins 2019 Expansion by Presenting Its Product Catalog at the Hemp/CBD Health & Beauty Care EPPS Trade Show With Scheduled Meetings With Some of the Largest Mass Market Retailers in the USA

07/01/2019 - 14:30

SUNRISE, Fla., Jan. 07, 2019 (GLOBE NEWSWIRE) -- Profile Solutions, Inc. (OTC Pink: PSIQ) announces its subsidiary Elite Products International, Inc. will be attending the Efficient Collaborative Retail Marketing (“ECRM [...]

Cocrystal Announces Board Changes

07/01/2019 - 14:30

BOTHELL, WA, Jan. 07, 2019 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc., a biotechnology company with a proprietary technology platform focused on developing medicines to treat viral diseases, today announced changes to [...]

Pain Therapeutics Announces Two New Peer-Reviewed Publications for REMOXY

07/01/2019 - 14:30

AUSTIN, Texas, Jan. 07, 2019 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq:PTIE), a clinical-stage drug development company, today announced two new publications for its drug candidate, REMOXY ER (extended-release [...]

Cutera Announces Leadership Change and Preliminary Financial Results for Full Year 2018

07/01/2019 - 14:30

CEO James Reinstein Resigns as President, Chief Executive Officer and Board member COO Jason Richey to Serve as Interim CEO BRISBANE, Calif., Jan. 07, 2019 (GLOBE NEWSWIRE) -- Cutera, Inc. ( CUTR ) (“Cutera” or the “ [...]

Aptevo Therapeutics Highlights Key 2019 Priorities

07/01/2019 - 14:30

ADAPTIR™ Bispecific Antibody Candidates Poised to Progress in Clinical Development APVO436 Advancing in Phase 1 Clinical Trial for Acute Myeloid Leukemia; APVO210 Beginning Phase 1 Clinical Trial in Q1 2019; ALG.APV-527 [...]

OrthoPediatrics Corp. Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2018

07/01/2019 - 14:30

WARSAW, Ind., Jan. 07, 2019 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced today its preliminary unaudited revenue for [...]

Checkpoint Therapeutics Initiates Registrational Development Programs for Anti-PD-L1 Antibody CK-301

07/01/2019 - 14:30

Ongoing endometrial and colorectal cancer cohorts intended to support BLA submissions NEW YORK, Jan. 07, 2019 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immuno- [...]

Enochian Biosciences Announces Appointment of Dr. Mark Dybul as Executive Vice-Chair

07/01/2019 - 14:30

LOS ANGELES, Jan. 07, 2019 (GLOBE NEWSWIRE) -- Enochian Biosciences, Inc. (“Enochian”) a biopharmaceutical company focused on the development and commercialization of novel therapies for HIV/AIDS and oncology, announced [...]

SeaSpine Announces Preliminary Results for Fourth Quarter and Full-Year 2018

07/01/2019 - 14:30

CARLSBAD, Calif., Jan. 07, 2019 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today [...]

Cellectar Provides Update on Phase 1 Trial of CLR 131 in Relapsed/Refractory Multiple Myeloma

07/01/2019 - 14:30

Median overall survival of 22.0 months observed in Cohorts 1-4 FLORHAM PARK, N.J., Jan. 07, 2019 (GLOBE NEWSWIRE) -- Cellectar Biosciences (Nasdaq: CLRB), a clinical-stage biopharmaceutical company focused on the [...]

Aura Announces Non-Brokered Private Placement of Up to $1,500,000

07/01/2019 - 14:19

TORONTO, Jan. 07, 2019 (GLOBE NEWSWIRE) -- Aura Health Inc. (the " Company " or “ Aura ”) ( CSE:BUZZ ) is pleased to announce that it is raising up to $1,500,000 by way of a non-brokered private placement of units of [...]

Allscripts Joins with Microsoft to Explore Technology for Clinical Research

07/01/2019 - 14:01

A new operating model to enable research as a natural output of clinical practice, through integration with point-of-care technology platforms and workflows CHICAGO, Jan. 07, 2019 (GLOBE NEWSWIRE) -- Today, Allscripts ( [...]

Sientra Announces Preliminary Unaudited Fourth Quarter 2018 Net Sales and Appointment of Aesthetic Industry Veteran to Board of Directors

07/01/2019 - 14:00

Anticipates total fourth quarter net sales of $19.0 million, growth of 72% year over year Aesthetic industry veteran Mary M. Fisher joins Sientra’s Board of Directors SANTA BARBARA, Calif., Jan. 07, 2019 (GLOBE NEWSWIRE [...]

BioTime Enters Into Exclusive Agreement With Orbit Biomedical Ltd. to Access Innovative Device for the Sub-Retinal Delivery of OpRegen® Cells for the Treatment of Dry-AMD

07/01/2019 - 14:00

ALAMEDA, Calif., Jan. 07, 2019 (GLOBE NEWSWIRE) -- BioTime, Inc. (NYSE American and TASE: BTX), a clinical-stage biotechnology company focused on degenerative diseases, today announced that it has entered into a [...]